Rasem Mourad

Array ( [id] => 7702834 [patent_doc_number] => 08088588 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Genetic products differentially expressed in tumors and the use of thereof' [patent_app_type] => utility [patent_app_number] => 12/326997 [patent_app_country] => US [patent_app_date] => 2008-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 41 [patent_no_of_words] => 29569 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088588.pdf [firstpage_image] =>[orig_patent_app_number] => 12326997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545407 [patent_doc_number] => 20090155284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'HGF-SF MONOCLONAL ANTIBODY COMBINATIONS' [patent_app_type] => utility [patent_app_number] => 12/326602 [patent_app_country] => US [patent_app_date] => 2008-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14959 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155284.pdf [firstpage_image] =>[orig_patent_app_number] => 12326602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391180 [patent_doc_number] => 20090208493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Compounds and methods for the selective inhibition of ABCB1, ABCC1 and ABCG2 transporters and the treatment of cancers, especially drug resistant cancers and high throughput flow cytometry assay to detect selective inhibitors' [patent_app_type] => utility [patent_app_number] => 12/315132 [patent_app_country] => US [patent_app_date] => 2008-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15929 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 44 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208493.pdf [firstpage_image] =>[orig_patent_app_number] => 12315132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5429245 [patent_doc_number] => 20090088555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => '44 Human Secreted Proteins' [patent_app_type] => utility [patent_app_number] => 12/274626 [patent_app_country] => US [patent_app_date] => 2008-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67615 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20090088555.pdf [firstpage_image] =>[orig_patent_app_number] => 12274626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5284370 [patent_doc_number] => 20090098045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of MCSP' [patent_app_type] => utility [patent_app_number] => 12/313298 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18751 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098045.pdf [firstpage_image] =>[orig_patent_app_number] => 12313298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6313792 [patent_doc_number] => 20100111872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'System and method for modulating and optimizing immunotherapy' [patent_app_type] => utility [patent_app_number] => 12/289861 [patent_app_country] => US [patent_app_date] => 2008-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8607 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20100111872.pdf [firstpage_image] =>[orig_patent_app_number] => 12289861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545412 [patent_doc_number] => 20090155289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'FURIN-CLEAVABLE PEPTIDE LINKERS FOR DRUG-LIGAND CONJUGATES' [patent_app_type] => utility [patent_app_number] => 12/264065 [patent_app_country] => US [patent_app_date] => 2008-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2881 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155289.pdf [firstpage_image] =>[orig_patent_app_number] => 12264065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6371034 [patent_doc_number] => 20100075304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'PROCESS FOR MONITORING COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 12/261885 [patent_app_country] => US [patent_app_date] => 2008-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5112 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075304.pdf [firstpage_image] =>[orig_patent_app_number] => 12261885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10522909 [patent_doc_number] => 09249409 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-02 [patent_title] => 'Method for detection of cancer' [patent_app_type] => utility [patent_app_number] => 12/739689 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 49108 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 283 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12739689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5415901 [patent_doc_number] => 20090041788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Apo-2L receptor agonist and CPT-11 synergism' [patent_app_type] => utility [patent_app_number] => 12/287811 [patent_app_country] => US [patent_app_date] => 2008-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22145 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041788.pdf [firstpage_image] =>[orig_patent_app_number] => 12287811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5360471 [patent_doc_number] => 20090035265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'Compositions and Methods for Targeted Delivery of Factors' [patent_app_type] => utility [patent_app_number] => 12/250126 [patent_app_country] => US [patent_app_date] => 2008-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 19190 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20090035265.pdf [firstpage_image] =>[orig_patent_app_number] => 12250126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11330984 [patent_doc_number] => 09522218 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-20 [patent_title] => 'Method for preparing porous scaffold for tissue engineering, cell culture and cell delivery' [patent_app_type] => utility [patent_app_number] => 12/681682 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6895 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12681682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476543 [patent_doc_number] => 20100285008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'BENZOQUINONE DERIVATIVE E3330 IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER AND ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 12/679824 [patent_app_country] => US [patent_app_date] => 2008-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 5998 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285008.pdf [firstpage_image] =>[orig_patent_app_number] => 12679824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4441222 [patent_doc_number] => 07927816 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Methods for identifying modulators of apoptosis' [patent_app_type] => utility [patent_app_number] => 12/206670 [patent_app_country] => US [patent_app_date] => 2008-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27527 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/927/07927816.pdf [firstpage_image] =>[orig_patent_app_number] => 12206670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5277973 [patent_doc_number] => 20090130105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'COMPOSITIONS THAT BIND MULTIPLE EPITOPES OF IGF-1R' [patent_app_type] => utility [patent_app_number] => 12/200816 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 110363 [patent_no_of_claims] => 165 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130105.pdf [firstpage_image] =>[orig_patent_app_number] => 12200816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5428550 [patent_doc_number] => 20090087860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'HIGHLY SENSITIVE SYSTEM AND METHODS FOR ANALYSIS OF PROSTATE SPECIFIC ANTIGEN (PSA)' [patent_app_type] => utility [patent_app_number] => 12/197159 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 44193 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087860.pdf [firstpage_image] =>[orig_patent_app_number] => 12197159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5586259 [patent_doc_number] => 20090105461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Calicheamicin conjugates' [patent_app_type] => utility [patent_app_number] => 12/221551 [patent_app_country] => US [patent_app_date] => 2008-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 30137 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105461.pdf [firstpage_image] =>[orig_patent_app_number] => 12221551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5409569 [patent_doc_number] => 20090123467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Polypeptide-Nucleic Acid Conjugate for Immunoprophylaxis or Immunotherapy for Neoplastic or Infectious Disorders' [patent_app_type] => utility [patent_app_number] => 12/184246 [patent_app_country] => US [patent_app_date] => 2008-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 60779 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123467.pdf [firstpage_image] =>[orig_patent_app_number] => 12184246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386231 [patent_doc_number] => 08263631 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Anti-cancer pharmaceutical compositions and methods for treating patients with cancer' [patent_app_type] => utility [patent_app_number] => 12/221019 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18363 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12221019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4778282 [patent_doc_number] => 20080286280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Stable Lyophilized Pharmaceutical Preparations of Monoclonal or polyclonal antibodies' [patent_app_type] => utility [patent_app_number] => 12/180794 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7972 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286280.pdf [firstpage_image] =>[orig_patent_app_number] => 12180794 [rel_patent_id] =>[rel_patent_doc_number] =>)